The effect of the upregulation of Tnfsf9 is difficult to define, because TNFSF9, also known as CD37 ligand and 4-1BBL, has a cell context dependent role in (auto) immune regulation [42], including type I diabetes [43], and in immune system homeostasis [44]. This evidence concerns the gene TNFSF9 and type 1 diabetes mellitus.